Palo Alto, California, United States In 2003 was created Biotechnology Development Fund VI, L.P., which is appeared as VC. The leading representative office of defined VC is situated in the Palo Alto. The fund was located in North America if to be more exact in United States.
This organization was formed by Edgar G. Engleman.
Among the most popular portfolio startups of the fund, we may highlight Pepgen Corporation. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. Among the most popular fund investment industries, there are Life Science, Health Care. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
The usual things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2004.
The usual cause for the fund is to invest in rounds with 4 partakers. The meaningful sponsors for the fund in investment in the same round are Veron International, Valley Ventures, Toucan Capital.
Funds with similar focus
| Fund Name | Location |
| 212 Ventures | New York, New York, United States |
| Art Venture | - |
| AVG Basecamp Fund | New York, New York, United States |
| Charles Schwab | California, San Francisco, United States |
| CTS Capital | - |
| DMGT | England, London, United Kingdom |
| Earth Space Robotics | - |
| Elliptic Ventures | Israel, Tel Aviv, Tel Aviv |
| Friedli Corporate Finance | Steinhausen, Switzerland, Zug |
| Genesee & Wyoming | Connecticut, Darien, United States |
| Green Harbor Investment | Chaoyang, China, Liaoning |
| HGI Capital Group | China, Hong Kong, Hong Kong Island |
| HuaQiao Capital | - |
| JIC Capital | Beijing, Beijing, China |
| Kaopu Wangluo | China, Foochow, Fujian |
| Naxyris | - |
| RSC Capital | New York, New York, United States |
| Tianchen Touzi | China, Dongyang, Zhejiang |
| Vaal Investment Partners | - |
| Vito One | Bayern, Germany, Munich |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Forbes Medi-Tech | $10M | 07 Jan 2004 | New Jersey, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Forbes Medi-Tech | $10M | 07 Jan 2004 | New Jersey, United States |
